KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elevance Health (ELV) Revenue (2016 - 2025)

Elevance Health (ELV) has disclosed Revenue for 17 consecutive years, with $49.3 billion as the latest value for Q4 2025.

  • Quarterly Revenue rose 8.51% to $49.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $198.3 billion through Dec 2025, up 16.58% year-over-year, with the annual reading at $197.6 billion for FY2025, 11.62% up from the prior year.
  • Revenue for Q4 2025 was $49.3 billion at Elevance Health, down from $50.7 billion in the prior quarter.
  • The five-year high for Revenue was $50.7 billion in Q3 2025, with the low at $16.6 billion in Q4 2022.
  • Average Revenue over 5 years is $39.7 billion, with a median of $41.2 billion recorded in 2022.
  • The sharpest move saw Revenue crashed 46.17% in 2022, then surged 163.15% in 2023.
  • Over 5 years, Revenue stood at $30.8 billion in 2021, then tumbled by 46.17% to $16.6 billion in 2022, then soared by 163.15% to $43.6 billion in 2023, then rose by 4.26% to $45.4 billion in 2024, then rose by 8.51% to $49.3 billion in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $49.3 billion, $50.7 billion, and $49.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.